Regulatory Considerations for Cybersecurity and Data Privacy in Digital Health and Medical Applications and Products
Washington, D.C., Senior Director of Science, Regulation & Policy Svetlana Lyapustina and counsel Katherine Armstrong penned an Inhalation Magazine article titled “Regulatory Considerations for Cybersecurity and Data Privacy in Digital Health and Medical Applications and Products.” The article discusses the challenges brought about by technological innovations in inhalation therapies, including mobile applications, devices and add-ons that enable electronic interactions with users.
Svetlana and Katherine explain that these innovations bring a new host of regulatory and legal considerations, and that companies face the challenge of maximizing data assets while minimizing their legal and regulatory risks. Their article offers an overview of the legal and regulatory landscape and offers guiding principles to companies developing new digital products.
Read “Regulatory Considerations for Cybersecurity and Data Privacy in Digital Health and Medical Applications and Products.”
The material contained in this communication is informational, general in nature and does not constitute legal advice. The material contained in this communication should not be relied upon or used without consulting a lawyer to consider your specific circumstances. This communication was published on the date specified and may not include any changes in the topics, laws, rules or regulations covered. Receipt of this communication does not establish an attorney-client relationship. In some jurisdictions, this communication may be considered attorney advertising.